IPO - Akebia Therapeutics, Inc.

Form Type: 8-K

Filing Date: 2025-03-20

Corporate Action: Ipo

Type: New

Accession Number: 000119312525059327

Filing Summary: On March 19, 2025, Akebia Therapeutics, Inc. entered into an underwriting agreement for a public offering of 25,000,000 shares of common stock at a price of $2.00 per share, with the underwriters agreeing to purchase at $1.88 per share. The estimated net proceeds from the offering are $46.5 million, potentially increasing to $53.6 million if the underwriters fully exercise their option for an additional 3,750,000 shares. The closing of the offering is scheduled for March 21, 2025, pending customary closing conditions. The company anticipates it is structured to reach profitability, although this is subject to various risks and uncertainties. A press release regarding the pricing of the offering was also issued on March 19, 2025, and is included as an exhibit with the 8-K report.

Document Link: View Document